Stroke with transfusions changing to hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload
Am I a good candidate for Glutathione IV therapy
This guide breaks down everything the research says, what BPC-157 is, how it works in the body, what the studies show, dosing protocols people use, side effects to watch for, and whether it makes sense for you
62 Suppl 9, pp
PARP (another cell death marker) was reduced by 77.5%
One week you feel fine, the next you are dragging through mornings, losing focus by mid-afternoon, and relying on caffeine just to keep up